1354791-03-9

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 85006-25-3 N,N-di(tert-butoxycarbonyl)hydroxylamine 
• 1354791-02-8 4-(acetyl-O-methoxyoxime)-4-bromo-3-methy-1-phenyl-1H-pyrazol-5(4H)-one 
• 4173-74-4 1-Phenyl-3-methyl-4-acetyl-5-pyrazolon 
• 89-25-8 edaravone 

Downstream Products

• 1354791-04-0 4-(N-hydroxylamine)-4-(acetyl-O-methoxyoxime)-N-phenyl-5-methyl-pyrazolone 

Relevant academic research and scientific papers

MELDRUM 'S ACID, BARBITURIC ACID AND PYRAZOLONE DERIVATIVES SUBSTITUTED WITH HYDROXYLAMINE AS HNO DONORS

The disclosed subject matter provides certain N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or development of a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular diseases, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and conditions responsive to nitroxyl therapy.